Home / Inspections / 1046583

FDA Inspection 1046583 — Biogen, Inc.

Biogen, Inc. — FEI 1220951

The FDA completed an inspection of Biogen, Inc. on February 13, 2018 in Cambridge, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 13, 2018
Fiscal Year
2018
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Cambridge, MA (United States)

Facility

Other inspections at this facility

  • 1190494 (NAI Fri Nov 04 2022 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1180550 (NAI Fri Sep 02 2022 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1133055 (VAI Tue Nov 10 2020 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1130379 (NAI Tue Sep 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1008333 (VAI Thu Apr 06 2017 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources